BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33099232)

  • 21. Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
    Rodler S; Apfelbeck M; Schulz GB; Ivanova T; Buchner A; Staehler M; Heinemann V; Stief C; Casuscelli J
    Eur Urol Focus; 2020 Sep; 6(5):1097-1103. PubMed ID: 32534969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General thoracic surgery services across Asia during the 2020 COVID-19 pandemic.
    Jheon S; Ahmed AD; Fang VW; Jung W; Khan AZ; Lee JM; Nakajima J; Sihoe AD; Thongcharoen P; Tsuboi M; Turna A
    Asian Cardiovasc Thorac Ann; 2020 Jun; 28(5):243-249. PubMed ID: 32396384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efforts of Lung Cancer Oncologists in the"With COVID-19"Era].
    Katakura S; Kobayashi N
    Gan To Kagaku Ryoho; 2021 Aug; 48(8):1007-1011. PubMed ID: 34404066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19).
    Fiorelli S; Massullo D; Ibrahim M; Piccioni F; Andreetti C; Vanni C; Rocco M; Rendina EA; Menna C
    Eur J Cardiothorac Surg; 2020 Oct; 58(4):676-681. PubMed ID: 32844172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings.
    Salari A; Shirkhoda M
    Oral Oncol; 2020 Jun; 105():104693. PubMed ID: 32291153
    [No Abstract]   [Full Text] [Related]  

  • 26. Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus.
    Manjandavida FP; Honavar SG; Kim U; Singh U; Menon V; Das S; Kaliki S; Palanivelu MS; Khetan V; Shah PK; Rishi P; Mulay K; Gandhi A; Vadhiraja BM; Reddy VA; Bhat S; Rao V
    Indian J Ophthalmol; 2020 Jul; 68(7):1281-1291. PubMed ID: 32587152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of COVID-19 pandemic on lung cancer treatment scheduling.
    Fujita K; Ito T; Saito Z; Kanai O; Nakatani K; Mio T
    Thorac Cancer; 2020 Oct; 11(10):2983-2986. PubMed ID: 32790028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional Survey.
    Hui JYC; Yuan J; Teoh D; Thomaier L; Jewett P; Beckwith H; Parsons H; Lou E; Blaes AH; Vogel RI
    Am J Clin Oncol; 2020 Oct; 43(10):679-684. PubMed ID: 32852291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
    Guckenberger M; Belka C; Bezjak A; Bradley J; Daly ME; DeRuysscher D; Dziadziuszko R; Faivre-Finn C; Flentje M; Gore E; Higgins KA; Iyengar P; Kavanagh BD; Kumar S; Le Pechoux C; Lievens Y; Lindberg K; McDonald F; Ramella S; Rengan R; Ricardi U; Rimner A; Rodrigues GB; Schild SE; Senan S; Simone CB 2nd; Slotman BJ; Stuschke M; Videtic G; Widder J; Yom SS; Palma D
    Radiother Oncol; 2020 May; 146():223-229. PubMed ID: 32342863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer treatment during COVID-19 pandemic.
    Jindal V; Sahu KK; Gaikazian S; Siddiqui AD; Jaiyesimi I
    Med Oncol; 2020 May; 37(7):58. PubMed ID: 32472216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MANAGING LUNG CANCER PATIENTS' CARE DURING THE COVID-19 PANDEMIC].
    Agbarya A; Khoury R; Nasser NJ; Lazri S; Volovik I; Gorenberg M
    Harefuah; 2020 Jul; 159(7):470-474. PubMed ID: 32720761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
    Passaro A; Addeo A; Von Garnier C; Blackhall F; Planchard D; Felip E; Dziadziuszko R; de Marinis F; Reck M; Bouchaab H; Peters S
    ESMO Open; 2020 Jun; 5(Suppl 3):. PubMed ID: 32581069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and cancer care: what do international guidelines say?
    Tartarone A; Lerose R
    Med Oncol; 2020 Aug; 37(9):80. PubMed ID: 32767203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP).
    Flick H; Arns BM; Bolitschek J; Bucher B; Cima K; Gingrich E; Handzhiev S; Hochmair M; Horak F; Idzko M; Jaksch P; Kovacs G; Kropfmüller R; Lamprecht B; Löffler-Ragg J; Meilinger M; Olschewski H; Pfleger A; Puchner B; Puelacher C; Prior C; Rodriguez P; Salzer H; Schenk P; Schindler O; Stelzmüller I; Strenger V; Täubl H; Urban M; Wagner M; Wimberger F; Zacharasiewicz A; Zwick RH; Eber E
    Wien Klin Wochenschr; 2020 Jul; 132(13-14):365-386. PubMed ID: 32533443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2).
    Cai Y; Xu Y; Xu D; Wang Y; Wang X; Sun C; Guo Y; Qiu S; Ma K
    Med Oncol; 2020 Aug; 37(9):78. PubMed ID: 32748212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic.
    Faivre-Finn C; Fenwick JD; Franks KN; Harrow S; Hatton MQF; Hiley C; McAleese JJ; McDonald F; O'Hare J; Peedell C; Pope T; Powell C; Rulach R; Toy E
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):481-489. PubMed ID: 32405158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer in the era of COVID-19: what can we expect?
    Araujo-Filho JAB; Normando PG; Melo MDT; Costa AN; Terra RM
    J Bras Pneumol; 2020 Oct; 46(6):e20200398. PubMed ID: 33111754
    [No Abstract]   [Full Text] [Related]  

  • 40. How we treat patients with lung cancer during the SARS-CoV-2 pandemic.
    Provencio M; Ruano-Raviña A
    ESMO Open; 2020 May; 4(Suppl 2):e000785. PubMed ID: 32409297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.